Abstract
The special extract of Cimicifuga racemosa (CR) BNO 1055 was shown to have bone protective effects without exerting estrogenic
effects in the uterus or mammary gland. Whether the effects of CR BNO 1055 would be
exerted in other organs that also express estrogen receptors (ERs) but in which the
effects of estrogens and of the selective estrogen receptor modulator raloxifen (Ral)
were not thoroughly studied was therefore investigated in the present contribution.
Rats were ovariectomized (ovx) and their food immediately substituted with estradiol
benzoate (EB), Ral or 2 doses of CR BNO 1055 for 3 months. Expressions of estrogen
receptor alpha (ERα), estrogen receptor beta (ERβ) and of insulin-like growth factor-1
(IGF-1) genes were determined in the vagina, liver, thyroid gland, lung, spleen, colon
and kidney by means of quantitative RT-PCRs. Body weights in all treatment groups
were significantly reduced and uterine weights in the EB treated animals were largely
and in the Ral treated animals slightly but significantly increased. CR BNO 1055 was
without effects in the uterus. We tested 3 genes: ERα gene expression was significantly
reduced in the vagina, liver and kidney and remained unaffected in all other organs
with the exception of the thyroid gland where ERα gene expression was stimulated by
EB, Ral had – if any – similar effects in these organs. The CR extract BNO 1055 was
devoid of any effect on ERα gene expression. ERβ gene expression was suppressed in
the vagina and colon by EB and this effect was shared by Ral in the colon. In the
thyroid, EB and Ral stimulated ERβ gene expression. Expression of IGF-1 gene was stimulated
by EB and CR BNO 1055 in the vagina and kidney and inhibited by EB and Ral in the
liver. No effects were observed by CR BNO 1055 in these organs. The effects of Ral,
if occurring, were similar to those of EB while CR BNO 1055 was ineffective in all
organs but the vagina. In the colon, reduced ERβ gene activity may augment ERα mediated
effects. In all other organs the effects of ER await further investigation. The CR
BNO 1055 did not show any activity pattern which would be similar to the pattern observed
under EB or Ral. Therefore the observed effects of CR BNO 1055 in these organs are
most likely not estrogenic in nature.
Key words
Cimicifuga racemosa
- Ranunculaceae - estradiol - ovariectomy - rat - uterus - vagina
References
1
Seidlova-Wuttke D, Hesse O, Jarry H, Christoffel V, Spengler B, Becker T, Wuttke W.
Evidence for selective estrogen receptor modulator activity in a black cohosh (Cimicifuga racemosa) extract: comparison with estradiol-17beta.
Eur J Endocrinol.
2003;
149
351-362
2
Seidlova-Wuttke D, Jarry H, Becker T, Christoffel V, Wuttke W.
Pharmacology of Cimicifuga racemosa extract BNO 1055 in rats: bone, fat and uterus.
Maturitas.
2003;
44 (Suppl. 1)
S39-S50
3
Lindberg M K, Moverare S, Skrtic S, Gao H, Dahlmann-Wright K, Gustafsson J A, Ohlsson C.
Estrogen receptor (ER)-beta reduces ERalpha-regulated gene transcription, supporting
a “ying yang” relationship between ERalpha and ERbeta in mice.
Mol Endocrinol.
2003;
17
203-208
4
Herynk M H, Fuqua S A.
Estrogen receptor mutations in human disease.
Endocr Rev.
2004;
25
869-898
5
Smith C L, O'Malley B W.
Coregulator function: a key to understanding tissue specificity of selective receptor
modulators.
Endocr Rev.
2004;
25
45-71
6
Clarke R, Liu M C, Bouker K B, Gu Z, Lee R Y, Zhu Y, Skaar T C, Gomez B, O'Brien K,
Wang Y, Hilakivi-Clarke L A.
Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling.
Oncogene.
2003;
22
7316-7339
7
Jetten A M, De Luca L M, Nelson K, Schroeder W, Burlingame S, Fujimoto W.
Regulation of cornifin alpha expression in the vaginal and uterine epithelium by estrogen
and retinoic acid.
Mol Cell Endocrinol.
1996;
123
7-15
8
Wang H, Eriksson H, Sahlin L.
Estrogen receptors alpha and beta in the female reproductive tract of the rat during
the estrous cycle.
Biol Reprod.
2000;
63
1331-1340
9
Miyagawa S, Suzuki A, Katsu Y, Kobayash M, Goto M, Handa H, Watanabe H, Iguchi T.
Persistent gene expression in mouse vagina exposed neonatally to diethylstilbestrol.
J Mol Endocrinol.
2004;
32
663-677
10
Stavreus-Evers A, Parini P, Freyschuss B, Elger W, Reddersen G, Sahlin L, Eriksson H.
Estrogenic influence on the regulation of hepatic estrogen receptor-alpha and serum
level of angiotensinogen in female rats.
J Steroid Biochem Mol Biol.
2001;
78
83-88
11
Escalada J, Sanchez-Franco F, Velasco B, Cacicedo L.
Regulation of growth hormone (GH) gene expression and secretion during pregnancy and
lactation in the rat: role of insulin-like growth factor-I, somatostatin, and GH-releasing
hormone.
Endocrinology.
1997;
138
3435-3443
12
Rossouw J E, Anderson G L, Prentice R L, LaCroix A Z, Kooperberg C, Stefanick M L,
Jackson R D, Beresford S A, Howard B V, Johnson K C, Kotchen J M, Ockene J.
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal
results from the Women's Health Initiative randomized controlled trial.
JAMA.
2002;
288
321-333
13
Wong N A, Malcomson R D, Jodrell D I, Groome N P, Harrison D J, Saunders P T.
ERbeta isoform expression in colorectal carcinoma: an in vivo and in vitro study of clinicopathological and molecular correlates.
J Pathol.
2005;
207
53-60
14
Koehler K F, Helguero L A, Haldosen L A, Warner M, Gustafsson J A.
Reflections on the discovery and significance of estrogen receptor beta.
Endocr Rev.
2005;
26
465-478
15
Ibrahim Y H, Yee D.
Insulin-like growth factor-I and cancer risk.
Growth Horm IGF Res.
2004;
14
261-269
16
Jarry H, Metten M, Spengler B, Christoffel V, Wuttke W.
In vitro effects of the Cimicifuga racemosa extract BNO 1055.
Maturitas.
2003;
44 (Suppl. 1)
S31-S38
17
Wober J, Weisswange I, Vollmer G.
Stimulation of alkaline phosphatase activity in Ishikawa cells induced by various
phytoestrogens and synthetic estrogens.
J Steroid Biochem Mol Biol.
2002;
83
227-233
18
Zierau O, Bodinet C, Kolba S, Wulf M, Vollmer G.
Antiestrogenic activities of Cimicifuga racemosa extracts.
J Steroid Biochem Mol Biol.
2002;
80
125-130
19
Mahmood I.
Interspecies scaling: predicting volumes, mean residence time and elimination half-life.
Some suggestions.
J Pharm Pharmacol.
1998;
50
493-499
20
Schneider K, Oltmanns J, Hassauer M.
Allometric principles for interspecies extrapolation in toxicological risk assessment
– empirical investigations.
Regul Toxicol Pharmacol.
2004;
39
334-347
21
Seidlova-Wuttke D, Thelen P, Wuttke W.
Inhibitory effects of a black cohosh (Cimicifuga racemosa ) extract on prostate cancer.
Planta Med.
2006;
72
521-526
22
Schlecht C, Klammer H, Jarry H, Wuttke W.
Effects of estradiol, benzophenone-2 and benzophenone-3 on the expression pattern
of the estrogen receptors (ER) alpha and beta, the estrogen receptor-related receptor
1 (ERR1) and the aryl hydrocarbon receptor (AhR) in adult ovariectomized rats.
Toxicology.
2004;
205
123-130
23
Spreafico E, Bettini E, Pollio G, Maggi A.
Nucleotide sequence of estrogen receptor cDNA from Sprague-Dawley rat.
Eur J Pharmacol.
1992;
227
353-356
24
Schoenfeld J R, Vasser M, Jhurani P, Ng P, Hunter J J, Ross Jr J, Chien K R, Lowe D G.
Distinct molecular phenotypes in murine cardiac muscle development, growth, and hypertrophy.
J Mol Cell Cardiol.
1998;
30
2269-2280
25
Gentry R T, Wade G N.
Sex differences in sensitivity of food intake, body weight, and running-wheel activity
to ovarian steroids in rats.
J Comp Physiol Psychol.
1976;
90
747-754
26
Ahdieh H B, Wade G N.
Effects of hysterectomy on sexual receptivity, food intake, running wheel activity,
and hypothalamic estrogen and progestin receptors in rats.
J Comp Physiol Psychol.
1982;
96
886-892
27
Mayes J S, Watson G H.
Direct effects of sex steroid hormones on adipose tissues and obesity.
Obes Rev.
2004;
5
197-216
28
Tarnopolsky M A.
Sex differences in exercise metabolism and the role of 17-beta estradiol.
Med Sci Sports Exerc.
2008;
40
648-654
29
Kretzschmar G, Nisslein T, Zierau O, Vollmer G.
No estrogen-like effects of an isopropanolic extract of Rhizoma Cimicifugae racemosae on uterus and vena cava of rats after 17 day treatment.
J Steroid Biochem Mol Biol.
2005;
97
271-277
30
Kalra M, Mayes J, Assefa S, Kaul A K, Kaul R.
Role of sex steroid receptors in pathobiology of hepatocellular carcinoma.
World J Gastroenterol.
2008;
14
5945-5961
31
Cosman F, Baz-Hecht M, Cushman M, Vardy M D, Cruz J D, Nieves J W, Zion M, Lindsay R.
Short-term effects of estrogen, tamoxifen and raloxifene on hemostasis: a randomized
controlled study and review of the literature.
Thromb Res.
2005;
116
1-13
32
Doerge D R, Chang H C.
Inactivation of thyroid peroxidase by soy isoflavones, in vitro and in vivo .
J Chromatogr B Analyt Technol Biomed Life Sci.
2002;
777
269-279
33
Siracusa M C, Overstreet M G, Housseau F, Scott A L, Klein S L.
17beta-estradiol alters the activity of conventional and IFN-producing killer dendritic
cells.
J Immunol.
2008;
180
1423-1431
34
Giroux V, Lemay F, Bernatchez G, Robitaille Y, Carrier J C.
Estrogen receptor beta deficiency enhances small intestinal tumorigenesis in ApcMin/+
mice.
Int J Cancer.
2008;
123
303-311
35
Mukundan H, Resta T C, Kanagy N L.
17Beta-estradiol decreases hypoxic induction of erythropoietin gene expression.
Am J Physiol Regul Integr Comp Physiol.
2002;
283
R496-R504
Prof. Dr. W. Wuttke
Department of Endocrinology University Medical Center Göttingen George-August-University
Robert-Koch-Str. 40
37075 Goettingen
Germany
Phone: + 49 5 51 39 67 14
Fax: + 49 5 51 39 65 18
Email: ufkendo@med.uni-goettingen.de